Stefani Thomas, PhD, Joins LMP
The Department of Laboratory Medicine and Pathology announces the appointment of Stefani Thomas to our faculty as an Assistant Professor, effective July 29th. Thomas will also be the Associate Director of the Masonic Children's Hospital Acute Care Laboratory. She comes to us from the Johns Hopkins University School of Medicine, Department of Pathology, where she was the Daniel W. Chan Fellow in Clinical Chemistry.
A native of Los Angeles, CA, Thomas graduated from Dartmouth College with B.A. in biological sciences and a minor in music. After working for a year as a lab technician, she entered graduate school at the University of Southern California where she pursued research on altered protein-signaling modules in Alzheimer’s disease using mass spectrometry-based proteomics methods. After earning her Ph.D. in pharmaceutical sciences, she worked as the manager of the University of Maryland’s Greenebaum Cancer Center Proteomics Shared Service for four years.
In 2012, Thomas joined Robert Cotter's laboratory in the Department of Pharmacology and Molecular Sciences at Johns Hopkins University as a postdoctoral research fellow and then was a research associate at JHU's Center for Biomarker Discovery and Translation (CBDT) in the Department of Pathology. Motivated by the growing prevalence of mass spectrometry in the clinical laboratory, she applied discovery and targeted proteomics methods to elucidate the biology of ovarian cancer and analyze proteins derived from alterations in cancer genomes and related biological processes. Thomas completed a clinical chemistry postdoctoral fellowship at Johns Hopkins in June 2019.
Regarding her interest in clinical chemistry, in a Hopkins Pathology Blog posting last year Thomas stated, “I am excited to synthesize my analytical chemistry skills, detail-oriented nature, enthusiasm for standards compliance, interest in process control, and penchant for clinical research.”
Thomas SN, Chen L, Liu Y, Höti N, and Zhang H. (2017) Targeted proteomic analyses of Histone H4 acetylation changes associated with homologous recombination deficient high-grade serous ovarian carcinomas. Journal of Proteome Research. 16:3704-3710.
Thomas SN*, Friedrich B*, Aebersold R, and Zhang H. Conservation of high-grade serous ovarian cancer biological signatures across proteomic platforms. Submitted. (*Co-1st authors)